IL123333A0 - 1-ar(alk)ylimidazolin-2-ones their preparation and pharmaceutical compositions containing them - Google Patents

1-ar(alk)ylimidazolin-2-ones their preparation and pharmaceutical compositions containing them

Info

Publication number
IL123333A0
IL123333A0 IL12333396A IL12333396A IL123333A0 IL 123333 A0 IL123333 A0 IL 123333A0 IL 12333396 A IL12333396 A IL 12333396A IL 12333396 A IL12333396 A IL 12333396A IL 123333 A0 IL123333 A0 IL 123333A0
Authority
IL
Israel
Prior art keywords
ylimidazolin
alk
ones
preparation
pharmaceutical compositions
Prior art date
Application number
IL12333396A
Other versions
IL123333A (en
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL123333(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of IL123333A0 publication Critical patent/IL123333A0/en
Publication of IL123333A publication Critical patent/IL123333A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12333396A 1995-09-05 1996-07-26 1-ar(alk)ylimidazolin-2-ones, their preparation and pharmaceutical compositions containing them IL123333A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (en) 1995-09-05 1995-09-05 Novel, anticonvulsant 1-ar (alk) yl-imidazolin-2-ones which contain a disubstituted amine radical in the 4-position, and process for their preparation
PCT/EP1996/003295 WO1997009314A1 (en) 1995-09-05 1996-07-26 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production

Publications (2)

Publication Number Publication Date
IL123333A0 true IL123333A0 (en) 1998-09-24
IL123333A IL123333A (en) 2001-10-31

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12333396A IL123333A (en) 1995-09-05 1996-07-26 1-ar(alk)ylimidazolin-2-ones, their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
EP (1) EP0863880B1 (en)
JP (1) JP4030578B2 (en)
CN (1) CN1103762C (en)
AR (1) AR003502A1 (en)
AT (1) ATE254606T1 (en)
AU (1) AU700602B2 (en)
BG (1) BG63917B1 (en)
BR (1) BR9610359A (en)
CA (1) CA2184871C (en)
CZ (1) CZ291839B6 (en)
DE (2) DE19532668A1 (en)
DK (1) DK0863880T3 (en)
EA (1) EA000535B1 (en)
EE (1) EE03562B1 (en)
ES (1) ES2208758T3 (en)
FR (1) FR13C0049I2 (en)
GE (1) GEP20022652B (en)
HK (1) HK1015776A1 (en)
HU (1) HU225956B1 (en)
IL (1) IL123333A (en)
LT (1) LT4482B (en)
LU (1) LU92263I2 (en)
NO (1) NO313829B1 (en)
NZ (1) NZ315624A (en)
PL (1) PL188287B1 (en)
PT (1) PT863880E (en)
SK (1) SK284868B6 (en)
TR (1) TR199800476T1 (en)
TW (1) TW422838B (en)
UA (1) UA46790C2 (en)
WO (1) WO1997009314A1 (en)
ZA (1) ZA967014B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (en) * 1997-05-23 1998-11-26 Dresden Arzneimittel Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
CA2531861A1 (en) * 2003-07-11 2005-01-20 Elbion Ag Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
EP3318247A1 (en) 2011-08-12 2018-05-09 Boehringer Ingelheim Vetmedica GmbH Taste masked pharmaceutical composition
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (en) 2021-01-18 2022-07-18 Procos Spa PROCESS FOR THE SYNTHESIS OF IMEPITOIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (en) 1971-10-21 1973-04-20 American Cyanamid Co NEW (P-CHLORO) PHENYL-1 METHYL-3 IMIDAZOLIDINES, 2,4-DISUBSTITUTIONS USEFUL IN PARTICULAR AS ANTIALDOSTERONE DIURETIC AGENTS AND THEIR PREPARATION PROCESS
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
IL123333A (en) 2001-10-31
CZ66198A3 (en) 1998-07-15
LT4482B (en) 1999-03-25
UA46790C2 (en) 2002-06-17
TR199800476T1 (en) 1998-06-22
DK0863880T3 (en) 2004-03-22
JPH11512101A (en) 1999-10-19
HUP9802941A3 (en) 1999-10-28
GEP20022652B (en) 2002-03-25
SK21698A3 (en) 1998-10-07
BG102287A (en) 1998-09-30
EE9800063A (en) 1998-08-17
EA199800271A1 (en) 1998-10-29
CA2184871C (en) 2001-08-21
LT98047A (en) 1998-10-26
TW422838B (en) 2001-02-21
NO313829B1 (en) 2002-12-09
ES2208758T3 (en) 2004-06-16
MX9801742A (en) 1998-08-30
AU700602B2 (en) 1999-01-07
CN1103762C (en) 2003-03-26
EP0863880B1 (en) 2003-11-19
DE59610827D1 (en) 2003-12-24
AR003502A1 (en) 1998-08-05
BG63917B1 (en) 2003-06-30
NZ315624A (en) 1998-11-25
JP4030578B2 (en) 2008-01-09
ATE254606T1 (en) 2003-12-15
PT863880E (en) 2004-04-30
WO1997009314A1 (en) 1997-03-13
HU225956B1 (en) 2008-01-28
CA2184871A1 (en) 1997-03-06
PL325413A1 (en) 1998-07-20
FR13C0049I2 (en) 2014-03-28
FR13C0049I1 (en) 2013-09-27
LU92263I2 (en) 2013-10-07
HUP9802941A2 (en) 1999-09-28
ZA967014B (en) 1997-08-18
CZ291839B6 (en) 2003-06-18
DE19532668A1 (en) 1997-03-06
CN1200728A (en) 1998-12-02
EA000535B1 (en) 1999-10-28
NO980906D0 (en) 1998-03-02
SK284868B6 (en) 2006-01-05
NO980906L (en) 1998-03-02
EP0863880A1 (en) 1998-09-16
EE03562B1 (en) 2001-12-17
AU6737596A (en) 1997-03-27
BR9610359A (en) 1999-07-06
HK1015776A1 (en) 1999-10-22
PL188287B1 (en) 2005-01-31

Similar Documents

Publication Publication Date Title
IL116512A0 (en) Cyclic peptides their preparation and pharmaceutical compositions containing them
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL117265A (en) Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them
IL117193A0 (en) Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL114925A0 (en) Glycinamide derivatives their preparation and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL119316A (en) Hydroxypyridinones their preparation and pharmaceutical compositions containing them
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
HUP9802290A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
IL112889A (en) Beta-lactams their preparation and pharmaceutical compositions containing them
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL117331A (en) Indole derivatives their preparation and pharmaceutical compositions containing them
IL114673A0 (en) Pharmaceutical compositions containing protein
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL123333A0 (en) 1-ar(alk)ylimidazolin-2-ones their preparation and pharmaceutical compositions containing them
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: ELBION GMBH

Free format text: FORMER NAME:ELBION AG

KB Patent renewed
KB Patent renewed
EXP Patent expired